Relevant bibliographies by topics / Gynecology Diagnosis

Academic literature on the topic 'Gynecology Diagnosis'

Author: Grafiati
Published: 10 December 2022
Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Gynecology Diagnosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Gynecology Diagnosis"

1

Levakov, S. A., A. G. Kedrova, and N. S. Wanke. "MODERN TRENDS TO LAPAROSCOPIC SURGERY IN GYNECOLOGY." Journal of Clinical Practice 1, no. 3 (September 15, 2010): 98–102. http://dx.doi.org/10.17816/clinpract1398-102.

Full text
Abstract:
Gynecologic laparoscopy has evolved from a limited surgical procedure used only for diagnosis and tubal ligations to a major surgical tool used to treat a multitude of gynecologic indications. Today, laparoscopy is one of the most common surgical procedures performed by gynecologists. The review presents the main trends of development of modern surgery in gynecology with the author's personal views on the key contentious issues of endoscopic sinus surgery.
APA, Harvard, Vancouver, ISO, and other styles
2

Djurdjevic, Srdjan, Lazar Racic, and Milan Zakula. "Gynecologic oncology surgical procedures in the General hospital ”dr. Radivoj Simonovic” in Sombor in the period from 2011-2021." Medical review 75, no. 3-4 (2022): 77–82. http://dx.doi.org/10.2298/mpns2204077d.

Full text
Abstract:
Introduction. In the period from 2011 - 2021, 1482 gynecologic surgeries were performed at the Department of Gynecology and Obstetrics of the General Hospital in Sombor, of which 50 (3.4%) were gynecologic oncology surgical procedures. The distribution of the malignant tumor localization was as follows: vulva 4 (8%), cervix 13 (26%), endometrium 24 (48%), and ovary 9 (18%). Material and Methods. The preoperative diagnosis of all patients included standard laboratory tests of blood and urine, chest X-ray, internal medicine specialist examination, electrocardiography, and imaging procedures (magnetic resonance imaging or computed tomography) of the small pelvis and abdomen. In all cases, the diagnosis of vulvar, cervical, and endometrial cancer was made preoperatively, based on pathohistological findings of the biopsy samples of tumor tissue or material obtained using exploratory curettage. In ovarian cancer, the diagnosis was made during surgery based on ex tempore pathohistological analysis. Results. Most of the operated patients were in the International Federation of Gynecology and Obstetrics stage I - 39 (78%) and the most common pathohistological type of tumor was adenocarcinoma of different localizations - 29 (58%). The number of lymph nodes removed per surgery was 16 - 39 (x: 19) and lymphovascular invasion was present in 31 (62%) operated patients. Intraoperative complications (bleeding, ureteral injury, infection, and wound dehiscence) occurred in 8 (16%) patients, recurrence occurred in 3 (6%), and postoperative lethal outcome occurred in 4 (8%) patients. Conclusion. The essential condition for performing gynecologic oncology surgical procedures in a secondary level healthcare facility is a well-trained gynecology surgeon who has received complete training in gynecologic oncology at the tertiary level, as well as the optimal number of gynecologic oncology surgeries in accordance with recommendations of the European Society of Gynecological Oncology.
APA, Harvard, Vancouver, ISO, and other styles
3

Soergel, Philipp, Martin Loning, Ismini Staboulidou, Cordula Schippert, and Peter Hillemanns. "Photodynamic Diagnosis and Therapy in Gynecology." Journal of Environmental Pathology, Toxicology and Oncology 27, no. 4 (2008): 307–20. http://dx.doi.org/10.1615/jenvironpatholtoxicoloncol.v27.i4.80.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

TAKEUCHI, HISAYA. "Ultrasound diagnosis in obstetrics and gynecology." Juntendo Medical Journal 45, no. 2 (1999): 184–94. http://dx.doi.org/10.14789/pjmj.45.184.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Boaventura, Camila Silva, José Lucas Scarpinetti Galvão, Giovanna Milanes Bego Soares, Almir Galvão Vieira Bitencourt, Rubens Chojniak, Shenia Lauanna Rezende Bringel, and Louise De Brot. "Synchronous gynecologic cancer and the use of imaging for diagnosis." Revista da Associação Médica Brasileira 62, no. 2 (April 2016): 116–19. http://dx.doi.org/10.1590/1806-9282.62.02.116.

Full text
Abstract:
Summary Endometrial and cervical cancers are the most prevalent gynecologic neoplasms. While endometrial cancer occurs in older women, cervical cancer is more prevalente in young subjects. The most common clinical manifestation in these two gynecological cancers is vaginal bleeding. In the first case, diagnosis is made based on histological and imaging evaluation of the endometrium, while cervical cancers are diagnosed clinically, according to the International Federation of Gynecology and Obstetrics (FIGO). The authors present a case of synchronous gynecological cancer of the endometrium and cervix diagnosed during staging on MRI and confirmed by histological analysis of the surgical specimen.
APA, Harvard, Vancouver, ISO, and other styles
6

Raju, Kalyani, Supreetha Megalamane Sunanda, and Varsha Shree Rajanna. "Cytology-histology correlation of gynecologic and non-gynecologic samples at a tertiary health care center: A two-year study." Biomedical Research and Therapy 6, no. 4 (April 29, 2019): 3096–106. http://dx.doi.org/10.15419/bmrat.v6i4.534.

Full text
Abstract:
Background: Cytology-histology correlation is a method of detection of an error in the diagnostic field. The root cause analysis is done for the discordant cases for quality improvement of the laboratory reports. Aims: To find out the root cause in discordant cytology-histology case pairs. Methods: This is a Retrospective cross-sectional descriptive study. The study was done from January 2016 to December 2017. All FNAC and Pap test cases which had corresponding biopsy slides and reports are included in the study. The discordant cases were classified as sampling error, interpretation error, cytology error, and histopathology error. Descriptive statistical analysis was used for the analysis of results. Results: Of total 639 case pairs, gynecologic case pairs were 447, and nongynecologic case pairs were 192. Among the gynecologic cases, the concordance between cytology and histopathology diagnosis were 425 (95%) and discordance 22 (5%) of which discrepancy in cytology was 11, histopathology was seven, and both cytology and histopathology error was four. The interpretation error was 14, and the sampling error was nine. Among non-gynecologic cases, the concordance between cytology and histopathology diagnosis were 167 (86%) and discordance 25 (14%) of which discrepancy in cytology was 17, histopathology was seven, and both cytology and histopathology error was one. The interpretation error was 16, and the sampling error was ten. The discordance versus concordance ratio was 1:19.3, 1:6.68 and 1:12.5 for gynecology, non-gynecology, and total case pairs respectively. Conclusions: The percentage of error in gynecologic cases was within the range of published data. However, those of non-gynecology cases were slightly higher. Regular professional training and improvement of sampling techniques especially the guided FNAC can reduce the errors.
APA, Harvard, Vancouver, ISO, and other styles
7

Schwarzman, Polina, Salvatore Andrea Mastrolia, Yael Sciaky-Tamir, Joel Baron, Boaz Sheizaf, Giuseppe Trojano, and Reli Hershkovitz. "Diagnosis of Tailgut Cyst in Gynecologic Patients: Systematic Review of the Literature." Journal of Endometriosis and Pelvic Pain Disorders 9, no. 3 (June 19, 2017): 168–73. http://dx.doi.org/10.5301/jeppd.5000293.

Full text
Abstract:
Tailgut cysts, also called retrorectal cystic hamartomas, are rare findings that usually occur in the retrorectal space. The incidence is estimated to be about 1 in 40,000. The aim of our review is to evaluate the potential pitfalls in the diagnosis of this rare pathologic condition, according to diagnostic procedures for this rare but misleading and subtle entity. We conducted a Medline literature review of the English literature discussing tailgut cysts in female patients. We concentrated on imaging technology used for diagnosis in gynecologic patients. For our search, we used the key words “tailgut cyst”, “retrorectal cystic hamartoma”, “gynecology”, focusing on clinical presentation, imaging technology used for diagnosis, presence of malignancy, and misdiagnosis with more common gynecologic pathology. Our search revealed 143 articles during the years 1975–2016 and, of these, 30 articles describing 91 female patients were considered. We concluded that tailgut cyst should be included in the differential diagnosis of pelvic lesions in gynecologic patients.
APA, Harvard, Vancouver, ISO, and other styles
8

Anrique, Denisse, Anja Anton, Karsten Krüger, Gesine Niedobitek-Kreuter, and Andreas D. Ebert. "Splenosis: An Uncommon Differential Diagnosis in Gynecology." Journal of Minimally Invasive Gynecology 20, no. 5 (September 2013): 708–9. http://dx.doi.org/10.1016/j.jmig.2013.03.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Santoso, Joseph T., Christine M. Lee, and Judith Aronson. "Discrepancy of death diagnosis in gynecology oncology." Gynecologic Oncology 101, no. 2 (May 2006): 311–14. http://dx.doi.org/10.1016/j.ygyno.2005.10.023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wang, Kuo-Gon, Tze-Chien Chen, Tao-Yeuan Wang, Yuh-Cheng Yang, and Tsung-Hsien Su. "Accuracy of Frozen Section Diagnosis in Gynecology." Gynecologic Oncology 70, no. 1 (July 1998): 105–10. http://dx.doi.org/10.1006/gyno.1998.5057.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Gynecology Diagnosis"

1

Bakour, Shagaf Haj. "Evaluation of ambulatory diagnosis of abnormal uterine bleeding." Thesis, University of Birmingham, 2003. http://etheses.bham.ac.uk//id/eprint/42/.

Full text
Abstract:
In the ambulatory assessment of women with abnormal uterine bleeding, the main aim is to reach a diagnosis and thereby allow appropriate treatment. Excluding endometrial pathology, particularly carcinoma and hyperplasia, is of paramount importance. However there is no consensus as to which set of investigations should be used (hysteroscopy, ultrasonography and endometrial sampling). There is a lack of good quality research evidence on the accuracy of the various diagnostic tests in predicting endometrial lesions. This dearth of relevant evidence prompted the research presented in this thesis to address and answer the following research questions: • What is the accuracy of outpatient miniature hysteroscopy / ultrasonography in the identification of premalignant and malignant endometrial lesions? • What is the relative significance of hysteroscopic and ultrasonographic evidence of endometrial atrophy in relation to an insufficient sample on outpatient endometrial biopsy? • What is the risk of premalignant and malignant pathology among endometrial polyps? What is the significance of various risk factors associated with endometrial polyps? • What is the feasibility of multivariable analysis to evaluate combinations of diagnostic tests in the diagnosis of endometrial disease? Findings and Conclusions Positive hhysteroscopy is accurate in ruling in endometrial cancer and hyperplasia (the LR was 51.1 (95% CI 7.9-326.9). Using endometrial thickness >4mm at ultrasound scan, ultrasound is accurate in ruling out endometrial cancer and hyperplasia (the LR was 0.14 (95%CI 0.02-0.64). Insufficient sample on endometrial biopsy was more common among cases with hysteroscopic finding of endometrial atrophy (adjusted OR= 4.79, 95% CI 1.05-21.91, p=0.04) and less common among cases with sonographic endometrial thickness above 5mm (adjusted OR=0.19, 95% CI 0.07-0.53, p=0.001). Therefore insufficient sample may be considered a substitute to absence of pathology provided the hysteroscopic and sonographic endometrial assessment is consistent with endometrial atrophy. Hyperplasia was more frequent in endometrial specimens with polyps than in those without (9.7% vs 4.8%, OR=2.1, 95% CI 0.85-5.2), but the rate of carcinoma in the two groups was not statistically different (4.8% vs 3.2%, OR=1.5, 95% CI 0.46-5.0). Tamoxifen treatment was associated with endometrial polyps (adjusted OR= 8.16, 95% CI 2.01-33.2, p=0.003) but hormone replacement therapy was not (adjusted OR=1.35, 95% CI 0.65 – 2.81, p=0.42). The true clinical value of a test lies in the added information over and above what was already known from the history and examination. It is feasible to develop a stepwise multivariable analytic approach to explore the added value of tests (hysteroscopy or ultrasonography) over and above history when predicting endometrial hyperplasia or cancer. This analytic strategy needs to be applied in larger datasets to draw clinical conclusions.
APA, Harvard, Vancouver, ISO, and other styles
2

Drury, Sarah L. "Molecular, morphological, and kinetic diagnosis of human preimplantation embryo vitality." Thesis, University of Warwick, 2016. http://wrap.warwick.ac.uk/88622/.

Full text
Abstract:
There have been phenomenal advances in the field of reproductive medicine and success rates following in vitro fertilisation have improved dramatically in recent years. The aim of this project was to improve our understanding of human preimplantation embryo development by identifying potential markers of viability that may aid us in selecting the best embryo for uterine transfer in the clinical embryology laboratory. Investigations into the distribution of cytoskeletal F-actin in human embryos demonstrated that a highly organised actin cortex is important for embryo cleavage and continued development to the blastocyst stage. Whilst they are polarised in the mouse from the oocyte to the blastocyst, the regulatory proteins leptin and STAT3 are co-localised only at the oocyte stage in humans, and are distributed within different cytoplasmic domains in human cleavage stage embryos and blastocysts. Whether polarity in humans is predetermined in the oocyte remains elusive, but none of the evidence generated in this thesis supports this idea. Leptin transiently activates STAT3 via the long form of the leptin receptor, and most significantly in the ICM of human day 6 blastocysts. Morphological features of blastocysts that can be visualised microscopically, such as a double ICM and cytoplasmic projections connecting the ICM to the TE, provide clues to their viability and may help us to choose the most suitable embryo from a cohort when deciding which to transfer. Nuclear volumes may in future contribute to this selection. Using time lapse technology to study cleavage patterns is now a routine occurrence in the clinical embryology laboratory. The results in this thesis show that distinctive patterns of divisions and the site at which blastocysts hatch can provide us with more information than a snap-shot morphological evaluation. Finally, contributing to the development of modelling software and predictive algorithms for the study of human embryos, particularly in time lapse imaging, means that our understanding of this fascinating area of medicine will continue to progress.
APA, Harvard, Vancouver, ISO, and other styles
3

Khan, Hamed N. "Serum autoantibodies as tumour markers in breast cancer : their role in screening, diagnosis and prognosis." Thesis, University of Nottingham, 2009. http://eprints.nottingham.ac.uk/10876/.

Full text
Abstract:
Introduction: Early diagnosis of breast cancer can result in less radical therapy and improved survival. Current screening and diagnostic tools have limitations, as do serum marker antigens due to their low sensitivity. We hypothesised that an immune response is an early event in cancer evolution. Autoantibodies, which are the amplified signals of cancer-derived antigens, can be detected in the peripheral blood of women with early breast cancer. This thesis is a continuation of previous work at the Nottingham Breast Unit aimed at developing new panel of assays for the detection of autoantibodies in breast cancer. The goal of this thesis was to investigate the use of a potentially more reproducible ELISA assay to measure serum autoantibodies to MUC1, p53 and c-myc either singly or in combination within a panel to further clarify a role of AAbs in screening, diagnosis or prognosis of primary breast cancer. Methods: Newly expressed, biotinylated and reconfigured p53 and c-myc antigens and purified MUC1 antigen were used to establish novel in-house ELISA. These were used to measure autoantibodies to the above 3 antigens in the serum of various populations which were collected over a two year period. These populations included an at-risk population (e.g. family history and atypical ductal hyperplasia) and a population of women who had just been diagnosed with primary breast cancer, either non-invasive ductal carcinoma in situ (DCIS) or invasive cancers. Cut-off values were established for each of the autoantibodies based on 2 or 3 standard deviations from the mean of a population of control samples. The control samples were obtained from a population of women who were either deemed ‘normal’ or who had a histological diagnosis of benign breast disease. The assay was validated by assessing effect of sample age as samples were of varying age, reproducibility using Bland Altman coefficient of reproducibility and reliability by establishing the assays ability to distinguish cancer from non-cancer. Results: Eight hundred and ninety eight samples were analysed in the study. One hundred and ten were Control samples. The remaining samples included 381 that were from an at-risk population and 407 that were from a primary breast cancer population. Mean ages of Control, at-risk and primary breast cancer populations were 58.8, 50 and 62.9 years respectively. Data establishing validity of assay confirmed that sample age did not affect signal strength for MUC1 and c-myc autoantibodies. Older samples for the p53 autoantibody had lower signal than recent ones. Reproducibility data was satisfactory and was best in the samples from the group of women with benign breast disease. Using either a 2 or 3 standard deviation cut-off value the assay was also able to distinguish cancer from non-cancer for both MUC1 and p53 autoantibodies. For the c-myc autoantibody, cancer samples showed increased signal compared to non-cancer although this did not reach significance. The at-risk population were routinely followed up in an outpatient clinic dedicated for women at increased risk of breast cancer. An individual positive marker was noted in up to 10% of at-risk patients. The panel of 3 assays showed a raised marker in 18.4%. This was significantly higher than that for the Control population whose panel detection was 9.1% whilst an individual marker was noted in up to 4.5% of samples. Only the c-myc autoantibody had similar prevalence in both Control and at-risk populations. There was no correlation between risk category and autoantibody detection. The specificity for MUC1, p53 and c-myc autoantibody serum tumour markers were 92.4%, 95.2% and 95% respectively. Specificity of the assay can be further increased if two or more markers were needed to be positive before a positive result is deemed for the assay. Thirteen women in the at-risk group developed breast cancer. The panel had a higher sensitivity to detect occult tumours compared to individual markers but at reduced specificity. Two of 13 at-risk patients (15.4%) who developed breast cancer had a raised marker (MUC1 & p53 autoantibodies) within the panel with a mean lead-time of 43.5 months. Further increasing the cut-off value to Mean + 4 standard deviation of Control population increased the specificity of the panel assay to 97.2% without altering the sensitivity to detect occult tumour (15.4%). Primary breast cancer population consisted of patients who were known to have DCIS or invasive breast cancer. The latter group was further subdivided into those who were detected via screening mammogram (screen-detected) and those who presented with a lump (symptomatic). Two of the 3 markers (p53 and c-myc autoantibodies) were significantly raised in the primary breast cancer population compared to the at-risk population as well as the Control group as detailed in earlier paragraph. Individual markers were detected in up to 20.9%, 10.3% and 9.8% for p53, c-myc and MUC1 autoantibodies respectively. The panel detection rate was 35.1%. The tumour markers showed limited use as a prognostic factor. Only the c-myc autoantibody correlated with a poorer survival due to distant metastasis in symptomatic breast cancers. Data for the screen-detected breast cancer cases showed that there were no correlation between any of the 3 serum marker detection and prognosis. Conclusion: Our data demonstrated the three autoantibody assays whether singly or in combination as a panel showed differences not only between cancer and non-cancer but also between Control and at-risk, as well as between at-risk and cancer. The panel showed that one or more assays were positive in 35% of breast cancers with a specificity of 83.6%. The specificity of the assay can be altered to meet clinical needs by either increasing the cut-off value or altering the markers within the panel. Current data in the literature suggests a number of markers that may be added or substituted into the panel to enhance the specificity and sensitivity. However a sensitivity of 15.4% for detection of occult tumour in the at-risk group makes any clinical application for screening in this group less cost effective using the version of the assays described in this thesis. The lead-time in the two patients who did show elevation of an autoantibody suggests that if the sensitivity and specificity can be improved that there is an in-vivo amplification signal, which might allow earlier identification of some breast cancers. Detection of c-myc autoantibodies indicates a poorer prognosis in the symptomatic group. The value of this information needs to be further determined in larger studies and within multivariate analysis. If the current results remain then there may be clinical implication to this early data. Comparison with previous data from the unit revealed that detection of cancer-associated autoantibodies in primary breast cancer and at-risk groups using this methodology appeared to be less sensitive. This may indicate that the current method has been successful in reducing background signal and hence reduce false positive results. It therefore appears that we have established a more reliable and reproducible assay compared to previous study to detect autoantibodies to tumour-associated antigens. However it is noted that this thesis reports single batches of antigens (MUC1, p53 and c-myc) used in the autoantibody assays. Investigation of differences in protein structure and immunogenicity between batches, which might also affect the sensitivity and specificity of these assays, was outside the scope of this thesis but is the subject of ongoing research by other members of the research group.
APA, Harvard, Vancouver, ISO, and other styles
4

Wilne, Sophie Helen. "The Pathways Project : developing guidelines to facilitate the diagnosis of childhood brain tumours." Thesis, University of Birmingham, 2011. http://etheses.bham.ac.uk//id/eprint/2881/.

Full text
Abstract:
The Pathways project was undertaken to devise guidelines to facilitate rapid diagnosis of paediatric brain tumours. Methods: A systematic review and meta-analysis of published data on paediatric brain tumour presentation and analysis of the presentation of children newly diagnosed with a brain tumour at four oncology centres was undertaken. The results informed a professional consensus process. Results: 74 papers met the inclusion criteria for the meta-analysis. 56 symptoms and signs at diagnosis were identified. The most frequent symptoms and signs at diagnosis were: headache (33%), nausea and vomiting (32%), abnormalities of gait and coordination (27%), and papilloedema (13%). 139 patients were recruited to a multi-centre cohort study. Symptoms and signs at disease onset and at diagnosis and factors associated with a long and short symptom interval were determined. A shorter symptom interval was associated with nausea and vomiting and motor system abnormalities. A longer symptom interval was associated with head tilt, cranial nerve palsies, endocrine and growth abnormalities and reduced visual acuity. A multi-disciplinary workshop and Delphi consensus voting were used to translate the evidence into a clinical guideline comprising 76 statements advising on the identification and assessment of children who may have a brain tumour.
APA, Harvard, Vancouver, ISO, and other styles
5

Strange, Heather. "Non-invasive prenatal diagnosis and testing : perspectives on the emergence and translation of a new prenatal testing technology." Thesis, Cardiff University, 2015. http://orca.cf.ac.uk/90887/.

Full text
Abstract:
This thesis presents findings from a qualitative study of the emergence and early clinical translation of non-invasive prenatal diagnosis (NIPD) in the UK. Drawing from interviews with a range of experts and users I track the enrolment and translation of this new prenatal testing technology across a variety of clinical and social spaces. I show how encounters with NIPD prompt deep critical examination of the moral, social and political implications - not only of the technology - but of the established clinical practices (routine and specialised prenatal testing) and specific policy contexts (prenatal screening programmes) within which NIPD has begun to sediment. I explore how, as NIPD advances at a rapid pace and emerges within a culturally and politically complex context, the technology both aligns with and disrupts routine practices of prenatal screening and diagnosis. I show how, as the technology divides into two major strands - NIPD and NIPT - at an early stage of development, and before becoming naturalised/normalised within the clinic, scientists, clinicians and policy makers attempt to pin down, define and ‘fix’ the technology, drawing upon and engaging in substantive practices of division, categorisation and classification. I explore ambiguities present within such accounts, highlighting dissenting voices and moments of problematisation, and following this, I show how the ‘troubling’ of boundaries prompts much examination of ethical and social concerns. As a location within which interviewees explored more contentious issues, I show how abortion emerged as central to the discussion of NIPD. I proceed to show how institutionalised, professionalised bioethical debate dominates mainstream discourse, and I explain how a particular construction of the informed, individual choice-maker is mobilised in order to locate moral and political responsibility for testing in the hands of individuals, and to distance political/organisational structures from entanglement with problematic concerns. I explore how clinicians and patients respond to this positioning in multiple ways, both assimilating and questioning the mainstream discourse of ‘informed choice’. In conclusion, I highlight the broader (bio)political aspects of NIPD’s emergence and translation within prenatal screening and diagnosis.
APA, Harvard, Vancouver, ISO, and other styles
6

Сумцов, Георгій Олексійович, Георгий Алексеевич Сумцов, Heorhii Oleksiiovych Sumtsov, Дмитро Георгійович Сумцов, Дмитрий Георгиевич Сумцов, and Dmytro Heorhiiovych Sumtsov. "Пути улучшения цитологической диагностики в онкогинекологии." Thesis, Издательство СумГУ, 2009. http://essuir.sumdu.edu.ua/handle/123456789/5721.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Karnaki, Panagiota. "Attitudes, practices and knowledge regarding cervical cancer screening among Greek women in the area of Perth." Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 2000. https://ro.ecu.edu.au/theses/1373.

Full text
Abstract:
The purpose of this thesis is to study the attitudes, practices and knowledge of Greek women in Perth, Western Australia, regarding cervical cancer screening. This is important because no study has yet examined the cervical screening pattern of this group, despite their low participation rate in screening programs. Qualitative semi-structured interviews among 15 Greek women in Perth were used for data collection. Interviews were conducted both in English and Greek. Eight out of the 15 women interviewed did not participate in frequent screening and many had had only one Pap test in their life. Culture and religion influenced negative attitudes towards cervical screening; these combined with strong emotions of fear towards the disease and lack of knowledge about the purpose of Pap tests, to create powerful barriers to screening. Preoccupation with morality and misconceptions about heredity and the symptomatology of cervical cancer also influenced attitudes towards Pap tests. Further, women's decisions to screen were influenced by the negative behaviour of General Practitioners. A preference was expressed for specialists/gynaecologists and an unwillingness to attend women's health centres.
APA, Harvard, Vancouver, ISO, and other styles
8

Julian, Claire. "Mortalité fœtale et périnatale : performance d'un protocole de diagnostic." Thesis, McGill University, 1989. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=61788.

Full text
Abstract:
This thesis deals with the performance of a diagnostic protocol designed to determine the underlying causes of early fetal and perinatal deaths. It is subdivided into three chapters. The first chapter is a review of the literature. It surveys the underlying causes of fetal and perinatal deaths and the informativeness of different tests applied to assess these causes. The second chapter is a manuscrrpt describing the real performance of one of these protocols applied since 1982 in a geographlcally determined area. This area, located in the south east of France, covers annually 23,000 births. This descriptive study carried out on 1019 consecutive stillbirths and perinatal deaths shows the importance of both clinical information and necropsy among the overall tests. This chapter is preceded by an overview of the context and the objectives. In the third chapter, written as a classical chapter of a thesis, a decision tree presents the theoretical performance of each relevant combination of tests for the diagnosis only of fetal causes of death. The theoretical informativeness of each test was coded with the aid of two medical geneticists. Non fetal causes are not considered in this part of the study because the underlying objective of the clinicians who implemented the protocol was only to screen genetic causes of death.
Cette thèse se divise en trois chapitres écrits dans le cadre d'une étude d'évaluation de la performance d'un protocole de diagnostic des causes initiales de mortalité foetale précoce et périnatale. Le premier chapitre est constitué d'une revue de la littérature sur les causes initiales de mortalité et sur l'informativité des examens clinique et paracliniques à la naissance d'un enfant mort-né. Le deuxième chapitre est un manuscrit d'article décrivant la performance réelle d'un protocole de diagnostic mis en place en 1982 dans une zone géographique délimitée du sud est de la France couvrant 23 000 naissances annuelles. Cette étude descriptive porte sur 1019 décès consécutifs. Elle montre l'importance de l'information clinique et de l'autopsie parmi l'ensemble des examens. Elle est précédée d'une présentation du contexte et des objectifs. Le troisième chapitre est rédigé non plus sous la forme d'un article scientifique mais comme un chapitre de thèse classique. Il présente un arbre de décision évaluant la performance théorique de chaque combinaison des différents éléments du protocole. Le codage de l'informativité théorique de chaque élement inclus dans le protocole a été réalisé en collaboration avec deux experts en génétique médicale. Cette performance a été considérée uniquement pour la détermination des causes fœtales de mortalité. En effet, ce protocole mis en place à l'initiative d'une équipe de médecins pédiatres et généticiens, avait seulement pour objectif initiai le dépistage des causes fœtales de décès d'origine génétique et non celles d'origine maternelle ou obstétricale.
APA, Harvard, Vancouver, ISO, and other styles
9

YOU, JEAN-ERIC. "Apport de la voie vaginale dans le diagnostic echographique en gynecologie et en obstetrique." Lyon 1, 1990. http://www.theses.fr/1990LYO1M330.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Honest, H. "Accuracy of tests for predicting spontaneous preterm birth : Systematic reviews of diagnostic research." Thesis, University of Birmingham, 2010. http://etheses.bham.ac.uk//id/eprint/542/.

Full text
Abstract:
Spontaneous preterm birth complicates about 3% of pregnancies before 34 weeks’ gestation and 7 – 12% before 37 weeks’ gestation. It is an important issue to public health worldwide. The aim of this thesis was to identify test(s) which would predict spontaneous preterm birth in early pregnancy when women are asymptomatic and in later pregnancy when they present with symptoms of threatened preterm labour, using systematic reviews and meta-analysis. If women at risk can be identified whether early in pregnancy or when they present with threatened preterm labour, interventions can be deployed to prevent or delay birth and to improve subsequent neonatal mortality/morbidity. Initially 40,243 title and abstract citations were scrutinised, resulting in shortlist of 1,650 full articles in which 319 were included in the systematic reviews, encompassing 22 tests. The quality of studies and accuracy of tests measured with likelihood ratio (LR) was generally poor. There were only a handful of studies for most of the tests. Few tests reached LR+ point estimates >5. In asymptomatic antenatal women these were ultrasonographic cervical funnelling and length measurement, cervico-vaginal prolactin and cervico-vaginal fetal fibronectin screening for predicting spontaneous preterm birth before 34 weeks’ gestation. In this group, tests with LR- point estimates approaching <0.2 were detection of uterine contraction (by mammary stimulating test) and amniotic fluid CRP measurement. In symptomatic women with threatened preterm labour tests with LR+ point estimate >5 were absence of fetal breathing movements, cervical length measurement, amniotic fluid IL6 and IL8, serum CRP and cervico-vaginal hcg for predicting birth within 2-7 days of testing. In this group tests with LR- point estimate <0.2 were measurement of cervico-vaginal hcg, cervical length measurement, absence of fetal breathing movement, amniotic fluid IL6 and IL8, and serum CRP for predicting birth within 2 - 7 days of testing. In conclusion, no exceptional, but many promising tests for predicting spontaneous preterm birth was identified to aid the development of evidence based practice.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Gynecology Diagnosis"

1

C, Berman Mimi, ed. Obstetrics and gynecology. Philadelphia: Lippincott, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1945-, Hackelöer B. J., Staudach A, and Wittmann B. K, eds. Ultrasound diagnosis in obstetrics and gynecology. Berlin: Springer-Verlag, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hansmann, Mandfred, Bernhard-Joachim Hackelöer, and Alfons Staudach. Ultrasound Diagnosis in Obstetrics and Gynecology. Edited by Bernd K. Wittmann. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70423-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

A, Macpherson Marion B., ed. Obstetrics and gynecology. London: Mosby-Wolfe, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

1954-, Deutinger J., and Kratochwil Alfred, eds. Endosonography in obstetrics and gynecology. Berlin: Springer-Verlag, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

1925-, Nichols David H., and Sweeney Patrick J. 1945-, eds. Ambulatory gynecology. 2nd ed. Philadelphia: Lippincott, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

H, DeCherney Alan, and Nathan Lauren, eds. Current obstetric & gynecologic diagnosis & treatment. 9th ed. New York: Lange Medical Books/McGraw-Hill, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Imaging in obstetrics and gynecology: A teaching file. Baltimore: Williams & Wilkins, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Asim, Kurjak, ed. CRC handbook of ultrasound in obstetrics and gynecology. Boca Raton, Fla: CRC Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Tindall, V. R. Diagnostic picture tests in obstetrics & gynecology. [Chicago]: Year Book Medical Publishers [distributor], 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Gynecology Diagnosis"

1

Ebell, Mark H. "Gynecology and Obstetrics." In Evidence-Based Diagnosis, 165–76. New York, NY: Springer New York, 2001. http://dx.doi.org/10.1007/978-1-4757-3514-7_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jordan, J. A. "Pitfalls in Colposcopic Diagnosis." In Gynecology and Obstetrics, 423–24. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70559-5_142.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zuckerwise, Lisa C., Karen Archabald, and Joshua Copel. "Prenatal diagnosis." In Evidence-based Obstetrics and Gynecology, 213–23. Chichester, UK: John Wiley & Sons, Ltd, 2018. http://dx.doi.org/10.1002/9781119072980.ch21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

von Fournier, D. "Early Diagnosis of Breast Carcinoma." In Gynecology and Obstetrics, 545–48. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70559-5_190.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ulmsten, U. "The Diagnosis of Stress Incontinence." In Gynecology and Obstetrics, 644–46. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70559-5_224.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zapata, Mya Rose. "Diagnosis and Treatment of Vulvovaginitis." In Handbook of Gynecology, 1–21. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-17002-2_25-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kelley, Angela S., and Molly B. Moravek. "Diagnosis and Management of Endometriosis." In Handbook of Gynecology, 1–10. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-17002-2_29-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zapata, Mya Rose. "Diagnosis and Treatment of Vulvovaginitis." In Handbook of Gynecology, 219–39. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-17798-4_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kelley, Angela S., and Molly B. Moravek. "Diagnosis and Management of Endometriosis." In Handbook of Gynecology, 281–90. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-17798-4_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Constance, Elizabeth Stephens, and Molly B. Moravek. "Diagnosis and Management of Ectopic Pregnancy." In Handbook of Gynecology, 1–14. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-17002-2_30-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Gynecology Diagnosis"

1

"Study on Ultrasound Diagnosis of Common Abdominal Obstetrics and Gynecology." In 2018 International Conference on Biomedical Engineering, Machinery and Earth Science. Francis Academic Press, 2018. http://dx.doi.org/10.25236/bemes.2018.046.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hamadicharef, Brahim. "A plea for AUC confidence intervals in diagnosis models used in gynecology." In 2010 3rd International Conference on Biomedical Engineering and Informatics (BMEI). IEEE, 2010. http://dx.doi.org/10.1109/bmei.2010.5639681.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hedri, A., A. Lebrecht, MJ Battista, A. Hasenburg, and M. Schmidt. "Male breast cancer: clinical presentation, diagnosis and therapy. A 30-year experience at the Department of Obstetrics and Gynecology, Medical Center Mainz, Germany." In 62. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe – DGGG'18. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1671602.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Queiroz, Bruna Gonçalves, and Ruffo Freitas-Junior. "THE INFLUENCE OF THE NAVIGATING NURSE BEFORE THE DIAGNOSIS AND START OF TREATMENT OF PATIENTS AFFECTED BY BREAST CANCER IN THE CITY OF GOIANIA (GO), BRAZIL." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2028.

Full text
Abstract:
Objective: To evaluate and measure the time reduction in days between diagnosis and the start of treatment in patients guided by the navigating nurse or in patients attending outpatient clinics in a cancer referring Hospital. Methodology: This is a retrospective, analytical cohort study. The study was carried out in a specialized cancer hospital located in the city of Goiânia, GO. Data collection was performed at the Gynecology and Breast Service (SGM), using the data available in the medical records of women who were seen for the first time during the period from August 2018 to July 2019. Patients who met the eligibility criteria were classified into two groups (i.e., navigated and un-navigated). The data were analyzed using the SPSS version 23 statistical package, adopting a significance level of 5% (p<0.05), and the nonparametric test (Mann– Whitney U-test). Results: In total, 59 patients were included in the study. The patients aged 40–59 years (50.8%). There was a significant reduction in the mean delay in the group of patients guided by the navigating nurse: between the first consultation until the procedure (biopsy) for the diagnosis of breast cancer performed from 82.97 (SD 131.99) to 19.05 (SD 32.84) days, p=0.023; from the first consultation to the biopsy result from 105.41 (SD 137.94) to 30.95 (SD 36.92) days, p=0.002; and from the procedure to the biopsy result from 22.43 (SD 17.42) to 11.91 (SD 10.09) days, p=0.002. Conclusion: The performance of the navigator nurse provided an important reduction in different time intervals, allowing greater agility in the assistance and management of women with breast cancer, in a cancer referral hospital.
APA, Harvard, Vancouver, ISO, and other styles
5

Singh, Nisha. "Cohort study of vulvar cancer cases over a period of 10 years." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685356.

Full text
Abstract:
Objective: To study the risk factors, management protocols and outcome of vulvar cancer cases over a period of 10 years in a tertiary care hospital. Methods: It is a retrospective cohort study of vulvar cancer from January 2004 to January 2014 at King George Medical University, Lucknow. Hospital records of 41 patients with histologically proven diagnosis of vulvar cancer were studied from Department of Obstetrics and Gynecology and Department of Radiotherapy. The presence of risk factors, stage of disease, treatment modalities used and disease outcome in terms survival were studied. The data collected was analyzed and compared with the published literature. Results: The mean age for diagnosis of vulvar cancer was 52 years and peak incidence was seen in age group of 50-70 years. Incidence was significantly more in multiparous (p = 0.001) and postmenopausal women (p = 0.007). An average of 4.1 cases were seen per year. 97.56% cases were squamous cell carcinomas including one case of verrucous carcinoma. Only one non-squamous case of Bowen’s disease was seen. 20 cases belonged to early stage (1 and 2) while 21cases had advanced disease (3 and 4). 48.78% cases were primarily treated with surgery, 26.83% with radiotherapy, 7.3% with chemotherapy and 17.07% with combined chemoradiation. 78% of surgically treated cases had mean survival of 5 years. Mean survival of 1 year was recorded in advanced disease cases. Limitation of the study was poor follow up after treatment. Conclusion: Incidence of vulvar cancer is significantly high in multiparous and postmenopausal women. Surgical treatment is the best option in early stage of disease (stage I and II) and gives high survival rates while advanced disease treated with chemoradiation has poor survival.
APA, Harvard, Vancouver, ISO, and other styles
6

Jaimes, V., E. Cespedes, and M. Malca. "135 Value of the biopsy of non-palpable lesions in the diagnosis of breast cancer. Oncological gynecology service. Hospital nacional edgardo rebagliati martins, lima, peru." In IGCS Annual 2019 Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-igcs.135.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Belyaeva, Ludmila A., Leila V. Adamyan, Vladimir P. Kozachenko, Alexander A. Stratonnikov, Eugene F. Stranadko, and Victor B. Loschenov. "Fluorescence diagnostics in oncological gynecology." In SPIE Proceedings, edited by Valery V. Tuchin. SPIE, 2003. http://dx.doi.org/10.1117/12.518631.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Panteleeva, Olga, Natalia Shakhova, Grigory Gelikonov, and Ekaterina Yunusova. "OCT in difficult diagnostic cases in gynecology." In European Conference on Biomedical Optics. Washington, D.C.: OSA, 2011. http://dx.doi.org/10.1364/ecbo.2011.809124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Panteleeva, Olga, Natalia Shakhova, Grigory Gelikonov, and Ekaterina Yunusova. "OCT in difficult diagnostic cases in gynecology." In European Conferences on Biomedical Optics, edited by Rainer A. Leitgeb and Brett E. Bouma. SPIE, 2011. http://dx.doi.org/10.1117/12.889879.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mangla, Akanksha, and Renuka Sinha. "Role of complementary cytology, colposcopy and histopathology in detecting premalignant and malignant lesions of cervix." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685253.

Full text
Abstract:
Objective: Cervical cancer is the second most common gynecologic malignancy worldwide. India alone accounts for one fifth of total number of cases worldwide. The aim of our study was to calculate sensitivity, specificity, positive predictive value, negative predictive value, false positive rate and false negative rate of complementary cytology and colposcopy with histopathology as gold standard for detection of premalignant and malignant cervical lesions. Methods: A cross sectional study was conducted at Vardhman Mahavir Medical College and Safdarjung hospital, Delhi, India. 100 non pregnant females with complaint of post coital or irregular vaginal bleeding and those who had unhealthy cervix on visual inspection were included in study. Results: Colposcopy exhibited a high degree of accuracy in diagnosis of high grade lesions. Overall sensitivity of cytology was 50% whereas that of colposcopy was 83.3%. Cytology had specificity of 93.4% whereas colposcopy had specificity of 89.4%. 100% of high grade and invasive cancers on colposcopy were associated with similar findings on histology. The degree of agreement between cytology and colposcopy with histology was significant (p<0.001). Conclusion: Colposcopy is sensitive method as compared to cytology, especially in the higher grade lesions and combination of both methods appears to be of higher diagnostic importance.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Gynecology Diagnosis"

1

Estimating costs of post-abortion services. General Hospital Aurelia Valdivieso, Oaxaca, Mexico. Population Council, 1999. http://dx.doi.org/10.31899/rh1999.1011.

Full text
Abstract:
Health care systems around the world are facing problems providing quality care with increasingly constrained resources. While modern practices and diagnostic tests have made pregnancy a much less risky event than in the past, not all pregnancies have a favorable outcome. Spontaneous abortion occurs in 15–45% of all known pregnancies, and studies show that 25% of all obstetric/gynecology hospital admissions are for incomplete abortion. Given the high level of resources devoted to treating this condition, it is imperative to develop cost-effective methodologies to provide quality care. Unsafe abortion performed by untrained and inexperienced providers is the fourth leading cause of maternal mortality in Mexico. Strengthening the capacity of health care institutions to provide high-quality post-abortion care services that are cost-effective, accessible, and sustainable is a major public health objective. To improve its service-delivery model, the Aurelio Valdivieso General Hospital in Oaxaca implemented a redesigned service model for women seeking care for incomplete abortion. The study detailed in this report assesses the cost and quality implications of this new service model.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Gynecology Diagnosis' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography